Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123702093 | 12370209 | 3 | F | 2014 | 20160713 | 20160516 | 20160716 | EXP | US-ASTRAZENECA-2016SE51262 | ASTRAZENECA | 71.00 | YR | F | Y | 0.00000 | 20160716 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123702093 | 12370209 | 1 | PS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 21153 | |||||||||||
| 123702093 | 12370209 | 2 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 21153 | |||||||||||
| 123702093 | 12370209 | 3 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 21153 | |||||||||||
| 123702093 | 12370209 | 4 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 21153 | 40 | MG | QD | ||||||||
| 123702093 | 12370209 | 5 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 21153 | 40 | MG | QD | ||||||||
| 123702093 | 12370209 | 6 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 21153 | 40 | MG | QD | ||||||||
| 123702093 | 12370209 | 7 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | GENERIC | 21153 | ||||||||||
| 123702093 | 12370209 | 8 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | GENERIC | 21153 | ||||||||||
| 123702093 | 12370209 | 9 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | GENERIC | 21153 | ||||||||||
| 123702093 | 12370209 | 10 | SS | ESOMEPRAZOLE MAGNESIUM. | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 0 | |||||||||||
| 123702093 | 12370209 | 11 | SS | ESOMEPRAZOLE MAGNESIUM. | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 0 | |||||||||||
| 123702093 | 12370209 | 12 | SS | ESOMEPRAZOLE MAGNESIUM. | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 0 | |||||||||||
| 123702093 | 12370209 | 13 | SS | ESOMEPRAZOLE MAGNESIUM. | ESOMEPRAZOLE MAGNESIUM | 1 | Unknown | 0 | |||||||||||
| 123702093 | 12370209 | 14 | SS | ESOMEPRAZOLE MAGNESIUM. | ESOMEPRAZOLE MAGNESIUM | 1 | Unknown | 0 | |||||||||||
| 123702093 | 12370209 | 15 | SS | ESOMEPRAZOLE MAGNESIUM. | ESOMEPRAZOLE MAGNESIUM | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123702093 | 12370209 | 1 | Oesophageal achalasia |
| 123702093 | 12370209 | 2 | Impaired gastric emptying |
| 123702093 | 12370209 | 3 | Reflux gastritis |
| 123702093 | 12370209 | 4 | Oesophageal achalasia |
| 123702093 | 12370209 | 5 | Impaired gastric emptying |
| 123702093 | 12370209 | 6 | Reflux gastritis |
| 123702093 | 12370209 | 7 | Oesophageal achalasia |
| 123702093 | 12370209 | 8 | Impaired gastric emptying |
| 123702093 | 12370209 | 9 | Reflux gastritis |
| 123702093 | 12370209 | 10 | Oesophageal achalasia |
| 123702093 | 12370209 | 11 | Impaired gastric emptying |
| 123702093 | 12370209 | 12 | Reflux gastritis |
| 123702093 | 12370209 | 13 | Oesophageal achalasia |
| 123702093 | 12370209 | 14 | Impaired gastric emptying |
| 123702093 | 12370209 | 15 | Reflux gastritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123702093 | 12370209 | OT |
| 123702093 | 12370209 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123702093 | 12370209 | Drug ineffective | |
| 123702093 | 12370209 | Hiatus hernia | |
| 123702093 | 12370209 | Hypophagia | |
| 123702093 | 12370209 | Oesophageal achalasia | |
| 123702093 | 12370209 | Pyloric stenosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |